An FDA committee is meeting Friday to determine if a second shot is needed for people who first received the Johnson & Johnson COVID-19 vaccine.
‘Break up’ with J&J? Some are ready to try Pfizer or Moderna as FDA panel considers boosters.
Related Articles
